Global clinical trial landscape
All sponsors, phases, and enrollment status for GLP-1 agonist trials across obesity and diabetes
Phase 2 and Phase 3 Alzheimer's disease and MCI trials with amyloid, tau, and lifestyle arms
PD-1/PD-L1 checkpoint inhibitor trials, CAR-T, and combination arms across tumor types
Orphan-designated trials actively enrolling: rare metabolic, neurological, and genetic conditions